BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

820 related articles for article (PubMed ID: 22493463)

  • 1. Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies.
    Inadomi JM; Vijan S; Janz NK; Fagerlin A; Thomas JP; Lin YV; Muñoz R; Lau C; Somsouk M; El-Nachef N; Hayward RA
    Arch Intern Med; 2012 Apr; 172(7):575-82. PubMed ID: 22493463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence to Competing Strategies for Colorectal Cancer Screening Over 3 Years.
    Liang PS; Wheat CL; Abhat A; Brenner AT; Fagerlin A; Hayward RA; Thomas JP; Vijan S; Inadomi JM
    Am J Gastroenterol; 2016 Jan; 111(1):105-14. PubMed ID: 26526080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is the patient activation measure associated with adherence to colonoscopy after a positive fecal occult blood test result?
    Azulay R; Valinsky L; Hershkowitz F; Magnezi R
    Isr J Health Policy Res; 2018 Dec; 7(1):74. PubMed ID: 30577883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preferences for colorectal cancer screening among racially/ethnically diverse primary care patients.
    Hawley ST; Volk RJ; Krishnamurthy P; Jibaja-Weiss M; Vernon SW; Kneuper S
    Med Care; 2008 Sep; 46(9 Suppl 1):S10-6. PubMed ID: 18725820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent racial and ethnic disparities in up-to-date colorectal cancer testing in medicare enrollees.
    Fenton JJ; Tancredi DJ; Green P; Franks P; Baldwin LM
    J Am Geriatr Soc; 2009 Mar; 57(3):412-8. PubMed ID: 19175435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effectiveness of a multifaceted intervention to improve adherence to annual colorectal cancer screening in community health centers: a randomized clinical trial.
    Baker DW; Brown T; Buchanan DR; Weil J; Balsley K; Ranalli L; Lee JY; Cameron KA; Ferreira MR; Stephens Q; Goldman SN; Rademaker A; Wolf MS
    JAMA Intern Med; 2014 Aug; 174(8):1235-41. PubMed ID: 24934845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of screening for colorectal cancer in the general population.
    Frazier AL; Colditz GA; Fuchs CS; Kuntz KM
    JAMA; 2000 Oct; 284(15):1954-61. PubMed ID: 11035892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening colonoscopy versus sigmoidoscopy: implications of a negative examination for cancer prevention and racial disparities in average-risk patients.
    Wu BU; Longstreth GF; Ngor EW
    Gastrointest Endosc; 2014 Nov; 80(5):852-61.e1-2. PubMed ID: 24814774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community-based preferences for stool cards versus colonoscopy in colorectal cancer screening.
    DeBourcy AC; Lichtenberger S; Felton S; Butterfield KT; Ahnen DJ; Denberg TD
    J Gen Intern Med; 2008 Feb; 23(2):169-74. PubMed ID: 18157581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary care colorectal cancer screening recommendation patterns: associated factors and screening outcomes.
    Feldstein AC; Perrin N; Liles EG; Smith DH; Rosales AG; Schneider JL; Lafata JE; Myers RE; Mosen DM; Glasgow RE
    Med Decis Making; 2012; 32(1):198-208. PubMed ID: 21652776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Racial minorities are more likely than whites to report lack of provider recommendation for colon cancer screening.
    May FP; Almario CV; Ponce N; Spiegel BM
    Am J Gastroenterol; 2015 Oct; 110(10):1388-94. PubMed ID: 25964227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in colonoscopy and fecal occult blood test use after the introduction of dual screening offers in Germany: Results from a large population-based study, 2003-2016.
    Chen C; Stock C; Jansen L; Chang-Claude J; Hoffmeister M; Brenner H
    Prev Med; 2019 Jun; 123():333-340. PubMed ID: 30946858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barriers to colorectal cancer screening in Latino and Vietnamese Americans. Compared with non-Latino white Americans.
    Walsh JM; Kaplan CP; Nguyen B; Gildengorin G; McPhee SJ; Pérez-Stable EJ
    J Gen Intern Med; 2004 Feb; 19(2):156-66. PubMed ID: 15009795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Participation in colorectal cancer screening among Chinese Americans.
    Yip MP; Tu SP; Chun A; Yasui Y; Taylor VM
    Asian Pac J Cancer Prev; 2006; 7(4):645-50. PubMed ID: 17250445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disparities in colorectal cancer screening rates among Asian Americans and non-Latino whites.
    Wong ST; Gildengorin G; Nguyen T; Mock J
    Cancer; 2005 Dec; 104(12 Suppl):2940-7. PubMed ID: 16276538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.
    Tsoi KK; Ng SS; Leung MC; Sung JJ
    Aliment Pharmacol Ther; 2008 Aug; 28(3):353-63. PubMed ID: 18638075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of continued mailed fecal tests in the patient-centered medical home: Year 3 of the Systems of Support to Increase Colon Cancer Screening and Follow-Up randomized trial.
    Green BB; Anderson ML; Chubak J; Fuller S; Meenan RT; Vernon SW
    Cancer; 2016 Jan; 122(2):312-21. PubMed ID: 26488332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of patient navigation on colorectal cancer screening in a community-based randomized controlled trial of urban African American adults.
    Horne HN; Phelan-Emrick DF; Pollack CE; Markakis D; Wenzel J; Ahmed S; Garza MA; Shapiro GR; Bone LR; Johnson LB; Ford JG
    Cancer Causes Control; 2015 Feb; 26(2):239-246. PubMed ID: 25516073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline Features and Reasons for Nonparticipation in the Colonoscopy Versus Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM) Study, a Colorectal Cancer Screening Trial.
    Robertson DJ; Dominitz JA; Beed A; Boardman KD; Del Curto BJ; Guarino PD; Imperiale TF; LaCasse A; Larson MF; Gupta S; Lieberman D; Planeta B; Shaukat A; Sultan S; Menees SB; Saini SD; Schoenfeld P; Goebel S; von Rosenvinge EC; Baffy G; Halasz I; Pedrosa MC; Kahng LS; Cassim R; Greer KB; Kinnard MF; Bhatt DB; Dunbar KB; Harford WV; Mengshol JA; Olson JE; Patel SG; Antaki F; Fisher DA; Sullivan BA; Lenza C; Prajapati DN; Wong H; Beyth R; Lieb JG; Manlolo J; Ona FV; Cole RA; Khalaf N; Kahi CJ; Kohli DR; Rai T; Sharma P; Anastasiou J; Hagedorn C; Fernando RS; Jackson CS; Jamal MM; Lee RH; Merchant F; May FP; Pisegna JR; Omer E; Parajuli D; Said A; Nguyen TD; Tombazzi CR; Feldman PA; Jacob L; Koppelman RN; Lehenbauer KP; Desai DS; Madhoun MF; Tierney WM; Ho MQ; Hockman HJ; Lopez C; Carter Paulson E; Tobi M; Pinillos HL; Young M; Ho NC; Mascarenhas R; Promrat K; Mutha PR; Pandak WM; Shah T; Schubert M; Pancotto FS; Gawron AJ; Underwood AE; Ho SB; Magno-Pagatzaurtundua P; Toro DH; Beymer CH; Kaz AM; Elwing J; Gill JA; Goldsmith SF; Yao MD; Protiva P; Pohl H; Kyriakides T;
    JAMA Netw Open; 2023 Jul; 6(7):e2321730. PubMed ID: 37432690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virtual colonoscopy, optical colonoscopy, or fecal occult blood testing for colorectal cancer screening: results of a pilot randomized controlled trial.
    You JJ; Liu Y; Kirby J; Vora P; Moayyedi P
    Trials; 2015 Jul; 16():296. PubMed ID: 26156248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.